Patients who used a proprietary eye drop delivery device (Eyedrop, Vanguard Design, São Paulo, Brazil) in a pilot study reported that it eased the instillation of hypotensive drops, especially if they weren’t used to using eye drops, the study authors report in the Journal of Clinical Ophthalmology.
Patients who used a proprietary eye drop delivery device (Eyedrop, Vanguard Design, São Paulo, Brazil) in a pilot study reported that it eased the instillation of hypotensive drops, especially if they weren’t used to using eye drops, the study authors report in the Journal of Clinical Ophthalmology. Use of the plastic device, into which the medication bottle is inserted, did not change the drops’ effectiveness nor the frequency of side effects.
“The improvement in patient adherence to treatment could result in better IOP control and lower risk of progression over time,” the authors wrote. “Further studies with larger sample sizes and longer follow-up are necessary in order to better investigate such aspects.”
The study included 32 patients, 44% of whom had glaucoma. No significant difference in mean IOP variation existed between those using the device and those not using it. Patients learned how to use the device via video and a handout that included written instructions and illustrations after initially using the device under physician supervision.
The researchers are from the United States and Brazil.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.